AROCLOR 1254, PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL), PCB 153 (2,2',4,4',5,5'-HEXACHLOROBIPHENYL), PCB 77 (3,3',4,4'-TETRACHLOROBIPHENYL) |
TOX-Non-Repro-Sublethal - organ/system effects |
liver weight (as percent of body weight) versus controls |
increased with PCB 77 |
4/treatment group |
Adult |
5 d |
Toxicity Factor Datasets |
AROCLOR 1254, PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL), PCB 153 (2,2',4,4',5,5'-HEXACHLOROBIPHENYL), PCB 77 (3,3',4,4'-TETRACHLOROBIPHENYL) |
TOX-Non-Repro-Sublethal - organ/system effects |
coproporphyrin levels in liver versus controls |
increased with Aroclor 1254 |
4/treatment group |
Adult |
5 d |
Toxicity Factor Datasets |
AROCLOR 1254, PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL), PCB 153 (2,2',4,4',5,5'-HEXACHLOROBIPHENYL), PCB 77 (3,3',4,4'-TETRACHLOROBIPHENYL) |
TOX-Non-Repro-Sublethal - organ/system effects |
liver ethoxyresorufin-O-deethylase activity versus controls |
increased with PCB 77 |
4/treatment group |
Adult |
5 d |
Toxicity Factor Datasets |
AROCLOR 1254, PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL), PCB 153 (2,2',4,4',5,5'-HEXACHLOROBIPHENYL), PCB 77 (3,3',4,4'-TETRACHLOROBIPHENYL) |
TOX-Non-Repro-Sublethal - organ/system effects |
liver ethoxyresorufin-O-deethylase activity versus controls |
decreased with PCB 153 |
4/treatment group |
Adult |
5 d |
Toxicity Factor Datasets |
AROCLOR 1254, PCB 126 (3,3',4,4',5-PENTACHLOROBIPHENYL), PCB 153 (2,2',4,4',5,5'-HEXACHLOROBIPHENYL), PCB 77 (3,3',4,4'-TETRACHLOROBIPHENYL) |
TOX-Non-Repro-Sublethal - organ/system effects |
liver ethoxyresorufin-O-deethylase activity versus controls |
increased with PCB 126 |
4/treatment group |
Adult |
5 d |
Toxicity Factor Datasets |
AROCLOR 1254 |
TOX-Non-Repro-Sublethal - organ/system effects |
aminopyrine N-demethylase and aldrin epoxidase activities versus controls |
increased after 4 or 12 weeks |
4/treatment group |
Adult |
4, 8, or 12 weeks |
Toxicity Factor Datasets |
AROCLOR 1254 |
TOX-Non-Repro-Sublethal - organ/system effects |
liver ethoxyresorufin-O-deethylase activity versus controls |
decreased after 4 weeks |
4/treatment group |
Adult |
4, 8, or 12 weeks |
Toxicity Factor Datasets |